Oppositely, BTK-deficient macrophages show defects in fungal phagocytosis and TLR-mediated phagocytosis of tumor cells seems to be impaired by ibrutinib treatment of macrophages, implying a relevant role of BTK in the phagocytic activity of innate immune cells (36, 37). The gene discussed is BTK; the disease is neoplasm.